B6;129-Ctsktm1Psa/Ph

Status

Available to order

EMMA IDEM:10406
Citation informationRRID:IMSR_EM:10406 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;129-Ctsktm1Psa/Ph
Alternative nameCathepsin K
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolCtsktm1Psa
Gene/Transgene symbolCtsk

Information from provider

ProviderPaul Saftig
Provider affiliationInstitute of Biochemistry, Christian-Albrechts-University of Kiel
Genetic informationCathepsin K-deficient mice by targeted inactivation of the cathepsin K gene (lysosomal cysteine proteinase K). A clone containing exons 6 to 8 of the mouse cathepsin K gene was isolated from a genomic l-EMBL-3 library. The neomycin phosphotransferase gene (Neo) was inserted in the HindIII site at the cDNA nucleotide position 857 under control of the phosphoglycerokinase, PGK, promoter. Insertion of the Neo cassette introduced a premature translational stop codon into the open reading frame of the cathepsin K gene. The targeting construct, pCK-Kpn(Neo), was used to disrupt the cathepsin K gene in embryonic stem cells. G418-resistant clones were screened by Southern analysis of genomic DNA. Mutated ESCs were microinjected into blastocysts of C57BL/6J females. The resulting chimeras were used to generate heterozygous and subsequently homozygous mutant offspring against an outbred 129/SvJ-C57BL/6J genetic background.
Phenotypic informationHomozygous:
Homozygous cathepsin K-deficient mice survive and are fertile; they manifest no overt phenotypic abnormalities until the age of 10 months.

Heterozygous:
Heterozygotes exhibit a normal phenotype and fertility.
References
  • Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.;Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz J D, Schu P, von Figura K, ;1998;Proceedings of the National Academy of Sciences of the United States of America;95;13453-8; 9811821
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreInstitute of Molecular Genetics, Prague, Czech Republic

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • decreased prepulse inhibition / IMPC
  • spermatogenesis defect / IMPC
  • osteopetrosis / IMPC
  • short tibia / IMPC
  • increased bone mineral density / IMPC
  • abnormal uterus morphology / IMPC
  • hypoplasia / IMPC
  • dysplasia / IMPC
MGI phenotypes (allele matching)
  • osteopetrosis / MGI
  • abnormal trabecular bone morphology / MGI
  • amyloidosis / MGI
  • thick pulmonary interalveolar septum / MGI
  • abnormal osteoclast physiology / MGI
  • abnormal bone structure / MGI
  • abnormal long bone diaphysis morphology / MGI
  • pulmonary fibrosis / MGI
  • increased long bone epiphyseal plate size / MGI
MGI phenotypes (gene matching)
  • fragile skeleton / MGI
  • increased bone mineral density / MGI
  • abnormal bone marrow cavity morphology / MGI
  • osteopetrosis / MGI
  • abnormal neurocranium morphology / MGI
  • abnormal tooth development / MGI
  • malocclusion / MGI
  • abnormal trabecular bone morphology / MGI
  • abnormal vertebrae morphology / MGI
  • abnormal jaw morphology / MGI
  • abnormal tibia morphology / MGI
  • ulcerated paws / MGI
  • amyloidosis / MGI
  • thick pulmonary interalveolar septum / MGI
  • decreased body height / MGI
  • decreased body weight / MGI
  • abnormal skeleton physiology / MGI
  • abnormal osteoclast physiology / MGI
  • postnatal growth retardation / MGI
  • abnormal bone remodeling / MGI
  • abnormal bone structure / MGI
  • abnormal compact bone morphology / MGI
  • abnormal alveolar process morphology / MGI
  • abnormal long bone diaphysis morphology / MGI
  • absent mandibular angle / MGI
  • abnormal bone resorption / MGI
  • abnormal osteoclast morphology / MGI
  • increased osteoclast cell number / MGI
  • abnormal osteoblast physiology / MGI
  • abnormal phalanx morphology / MGI
  • growth/size/body region phenotype / MGI
  • skeleton phenotype / MGI
  • abnormal skeleton morphology / MGI
  • pulmonary fibrosis / MGI
  • increased long bone epiphyseal plate size / MGI
  • increased diameter of tibia / MGI
  • increased bone trabecula number / MGI
  • increased trabecular bone mass / MGI
  • decreased bone volume / MGI
  • increased trabecular bone volume / MGI
  • increased compact bone area / MGI
  • wide cranial sutures / MGI
  • thin neurocranium / MGI
  • large fontanelles / MGI

Literature references

  • Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.;Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz J D, Schu P, von Figura K, ;1998;Proceedings of the National Academy of Sciences of the United States of America;95;13453-8; 9811821

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).